Paolo Nuciforo MD, PhD

Paolo Nuciforo MD, PhD, board certified Pathologist, Principal Investigator of the Molecular Oncology group at Vall d`Hebron Institute of Oncology (VHIO, http://www.vhio.net/en/molecular-oncology-group). He head a group of 12 fully trained personnel specialized in different histopathology and molecular pathology areas. The group is one of the cutting-edge core technology laboratory of VHIO which supports the different preclinical and clinical research programs. As part of the institution prescreening program, it performs molecular profiling in over 1500 patients per year as candidates for enrolment in early phase clinical trials. The laboratory is ISO15189-accredited and serves as central laboratory in several national and international clinical trials. Main research activities include discovery and validation of novel biomarkers using tissue-based technologies, development and application of novel molecular pathology strategies to basic, translational and clinical oncology. He has 10+ years of experience in oncology translational medicine and drug development both in academic and pharmaceutical environment. He co-authored over 80 publications in peer-reviewed journals with a main focus on discovery and validation of novel biomarkers using tissue-based technologies.